STOCK TITAN

[Form 4] GLAUKOS Corp Insider Trading Activity

Filing Impact
(Low)
Filing Sentiment
(Negative)
Form Type
4

Glaukos insider sale disclosed: Tomas Navratil, Chief Development Officer, reported multiple dispositions of Glaukos common stock on September 22-23, 2025. The sales were effected pursuant to a Rule 10b5-1 trading plan adopted June 12, 2025. Transaction prices ranged from $82.20 to $85.11 (weighted averages reported per block). After the reported transactions, the reporting person beneficially owned 75,907 shares, which include unvested restricted stock units (the filing notes 42,535 RSUs still unvested). Some shares were withheld to satisfy tax withholding upon RSU vesting.

Vendita da insider di Glaukos comunicata: Tomas Navratil, Chief Development Officer, ha riferito diverse cessioni di azioni ordinarie Glaukos il 22-23 settembre 2025. Le vendite sono state effettuate ai sensi di un piano di trading Rule 10b5-1 adottato il 12 giugno 2025. I prezzi delle transazioni variavano da $82.20 a $85.11 (medie ponderate riportate per blocco). Dopo le transazioni riportate, la persona che segnala deteneva 75.907 azioni, tra cui RSU non vestiti (nella dichiarazione sono indicati 42.535 RSU ancora non vestiti). Alcune azioni sono state trattenute per soddisfare le ritenute fiscali al vesting degli RSU.

Venta de insider de Glaukos divulgada: Tomas Navratil, Director de Desarrollo, informó de varias disposiciones de acciones ordinarias de Glaukos los 22-23 de septiembre de 2025. Las ventas se realizaron conforme a un plan de negociación Rule 10b5-1 adoptado el 12 de junio de 2025. Los precios de las transacciones oscilaron entre $82.20 y $85.11 (promedios ponderados reportados por bloque). Después de las transacciones reportadas, la persona reportante poseía 75,907 acciones, que incluyen unidades de acciones restringidas no vestidas (la presentación señala que 42,535 RSU aún no han vestido). Algunas acciones fueron retenidas para satisfacer la retención de impuestos al vesting de los RSU.

글로우콧 insider 매매 공시: Tomas Navratil, 최고 개발 책임자(CDO),는 2025년 9월 22-23일에 글로우콧 보통주의 다수의 처분을 보고했습니다. 매매는 2025년 6월 12일에 채택된 Rule 10b5-1 트레이딩 플랜에 따라 이루어졌습니다. 거래 가격은 $82.20에서 $85.11까지(블록별 가중평균으로 보고). 보고된 거래 이후 보고자는 75,907주의 보유 지분을 가지게 되었으며, 그 중 미 vest RSU 포함 (공시에는 42,535 RSU가 아직 vest되지 않은 것으로 명시). RSU vesting 시 필요한 세금 원천징수를 충당하기 위해 일부 주식이 보류되었습니다.

Vente d'initié chez Glaukos divulguée : Tomas Navratil, directeur du développement, a rapporté plusieurs cessions d'actions ordinaires Glaukos les 22 et 23 septembre 2025. Les ventes ont été effectuées dans le cadre d'un plan de trading Rule 10b5-1 adopté le 12 juin 2025. Les prix des transactions variaient de $82,20 à $85,11 (moyennes pondérées reportées par bloc). Après les transactions signalées, la personne déclarante détenait 75 907 actions, qui incluent des unités d'actions restreintes non vesting (le dossier indique que 42 535 RSU restent non vesting). Certaines actions ont été retenues pour couvrir les retenues d'impôt lors du vesting des RSU.

Insider-Verkauf bei Glaukos offengelegt: Tomas Navratil, Chief Development Officer, berichtete über mehrere Veräußerungen von Glaukos-Stammaktien am 22.-23. September 2025. Die Verkäufe erfolgten gemäß einem Rule-10b5-1-Handelsplan, der am 12. Juni 2025 aufgenommen wurde. Die Transaktionspreise lagen im Bereich von $82,20 bis $85,11 (gewichtete Durchschnitte pro Block). Nach den gemeldeten Transaktionen besaß die meldende Person 75.907 Aktien, wovon unverfallbare Restricted Stock Units eingeschlossen sind (die Einreichung vermerkt, dass 42.535 RSU noch vesten). Einige Aktien wurden einbehalten, um die Steuerrückbehalte bei RSU-Vesting zu decken.

كشف بيع داخلي في Glaukos: توماس ناتراتيل، رئيس التطوير، أبلغ عن عدة تصرفات في أسهم Glaukos العادية في 22-23 سبتمبر 2025. جرت المبيعات وفقاً لـ خطة تداول Rule 10b5-1 المعتمدة في 12 يونيو 2025. تراوحت أسعار المعاملات بين $82.20 و$85.11 (متوسطات موزونة مُبلغ عنها لكل كتلة). بعد المعاملات المذكورة، امتلك الشخص المبلّغ عنه ما 75,907 سهم، والتي تشمل وحدات أسهم مقيدة غير vesting (تشير الأوراق إلى أن 42,535 RSU لا تزال غير vesting). تم حجز بعض الأسهم لتلبية تطبيق ضرائب الحجز عند vesting RSU.

Glaukos 内幕交易披露: Tomas Navratil,首席开发官,报告在2025年9月22-23日对 Glaukos普通股进行多笔处置。交易根据于2025年6月12日通过的Rule 10b5-1交易计划执行。交易价格区间为$82.20至$85.11(按块报告的加权平均)。在交易后,报告人实际持有75,907股,其中包含未归属的限制性股票单位(披露指出仍有42,535股RSU未归属)。为在RSU归属时满足税务扣缴,部分股票被扣留。

Positive
  • Sales executed under a Rule 10b5-1 trading plan, providing an established pre-clearance mechanism and increased disclosure clarity
  • Filing discloses weighted-average price ranges and RSU tax-withholding, offering transparency about the transactions and resulting holdings
Negative
  • Officer disposed of multiple blocks of common stock on September 22-23, 2025, reducing immediate direct ownership to 75,907 shares
  • Significant portion of reported position consists of unvested RSUs (the filing states 42,535 RSUs still unvested), which may affect near-term share delivery and withholding activity

Insights

TL;DR: Insider executed multiple Rule 10b5-1 sales in late September; reporting shows retained beneficial ownership of 75,907 shares including unvested RSUs.

The Form 4 documents routine dispositions by an officer under a pre-established trading plan adopted June 12, 2025, with trades executed September 22-23, 2025 at weighted average prices reported for each block between $82.20 and $85.11. The filing discloses that a portion of the position consists of restricted stock units not yet vested and that shares were withheld for tax withholding related to RSU delivery. This is a standard Section 16 disclosure and does not by itself provide operational or financial guidance about the issuer.

TL;DR: Disclosure aligns with governance best practices: sales under a 10b5-1 plan and tax-withholding events are explicitly described.

The report clearly states the 10b5-1 plan adoption date and provides weighted-average price ranges for executed trades, plus details on RSUs and withholding. From a governance and compliance perspective, the filing meets transparency expectations for insider trading disclosures. No amendments or unexplained events are presented.

Vendita da insider di Glaukos comunicata: Tomas Navratil, Chief Development Officer, ha riferito diverse cessioni di azioni ordinarie Glaukos il 22-23 settembre 2025. Le vendite sono state effettuate ai sensi di un piano di trading Rule 10b5-1 adottato il 12 giugno 2025. I prezzi delle transazioni variavano da $82.20 a $85.11 (medie ponderate riportate per blocco). Dopo le transazioni riportate, la persona che segnala deteneva 75.907 azioni, tra cui RSU non vestiti (nella dichiarazione sono indicati 42.535 RSU ancora non vestiti). Alcune azioni sono state trattenute per soddisfare le ritenute fiscali al vesting degli RSU.

Venta de insider de Glaukos divulgada: Tomas Navratil, Director de Desarrollo, informó de varias disposiciones de acciones ordinarias de Glaukos los 22-23 de septiembre de 2025. Las ventas se realizaron conforme a un plan de negociación Rule 10b5-1 adoptado el 12 de junio de 2025. Los precios de las transacciones oscilaron entre $82.20 y $85.11 (promedios ponderados reportados por bloque). Después de las transacciones reportadas, la persona reportante poseía 75,907 acciones, que incluyen unidades de acciones restringidas no vestidas (la presentación señala que 42,535 RSU aún no han vestido). Algunas acciones fueron retenidas para satisfacer la retención de impuestos al vesting de los RSU.

글로우콧 insider 매매 공시: Tomas Navratil, 최고 개발 책임자(CDO),는 2025년 9월 22-23일에 글로우콧 보통주의 다수의 처분을 보고했습니다. 매매는 2025년 6월 12일에 채택된 Rule 10b5-1 트레이딩 플랜에 따라 이루어졌습니다. 거래 가격은 $82.20에서 $85.11까지(블록별 가중평균으로 보고). 보고된 거래 이후 보고자는 75,907주의 보유 지분을 가지게 되었으며, 그 중 미 vest RSU 포함 (공시에는 42,535 RSU가 아직 vest되지 않은 것으로 명시). RSU vesting 시 필요한 세금 원천징수를 충당하기 위해 일부 주식이 보류되었습니다.

Vente d'initié chez Glaukos divulguée : Tomas Navratil, directeur du développement, a rapporté plusieurs cessions d'actions ordinaires Glaukos les 22 et 23 septembre 2025. Les ventes ont été effectuées dans le cadre d'un plan de trading Rule 10b5-1 adopté le 12 juin 2025. Les prix des transactions variaient de $82,20 à $85,11 (moyennes pondérées reportées par bloc). Après les transactions signalées, la personne déclarante détenait 75 907 actions, qui incluent des unités d'actions restreintes non vesting (le dossier indique que 42 535 RSU restent non vesting). Certaines actions ont été retenues pour couvrir les retenues d'impôt lors du vesting des RSU.

Insider-Verkauf bei Glaukos offengelegt: Tomas Navratil, Chief Development Officer, berichtete über mehrere Veräußerungen von Glaukos-Stammaktien am 22.-23. September 2025. Die Verkäufe erfolgten gemäß einem Rule-10b5-1-Handelsplan, der am 12. Juni 2025 aufgenommen wurde. Die Transaktionspreise lagen im Bereich von $82,20 bis $85,11 (gewichtete Durchschnitte pro Block). Nach den gemeldeten Transaktionen besaß die meldende Person 75.907 Aktien, wovon unverfallbare Restricted Stock Units eingeschlossen sind (die Einreichung vermerkt, dass 42.535 RSU noch vesten). Einige Aktien wurden einbehalten, um die Steuerrückbehalte bei RSU-Vesting zu decken.

SEC Form 4
FORM 4 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number: 3235-0287
Estimated average burden
hours per response: 0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
1. Name and Address of Reporting Person*
Navratil Tomas

(Last) (First) (Middle)
C/O GLAUKOS CORPORATION
ONE GLAUKOS WAY

(Street)
ALISO VIEJO CA 92656

(City) (State) (Zip)
2. Issuer Name and Ticker or Trading Symbol
GLAUKOS Corp [ GKOS ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
Director 10% Owner
X Officer (give title below) Other (specify below)
CHIEF DEVELOPMENT OFFICER
3. Date of Earliest Transaction (Month/Day/Year)
09/22/2025
4. If Amendment, Date of Original Filed (Month/Day/Year)
6. Individual or Joint/Group Filing (Check Applicable Line)
X Form filed by One Reporting Person
Form filed by More than One Reporting Person
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year) 2A. Deemed Execution Date, if any (Month/Day/Year) 3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V Amount (A) or (D) Price
Common Stock 09/22/2025 S(1) 23 D $82.79(2) 76,884(3) D
Common Stock 09/22/2025 S(1) 218 D $83.76(4) 76,666(3) D
Common Stock 09/22/2025 S(1) 276 D $84.7(5) 76,390(3) D
Common Stock 09/23/2025 F 483(6) D $84.69 75,907(7) D
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year) 3A. Deemed Execution Date, if any (Month/Day/Year) 4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year) 7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
Explanation of Responses:
1. The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on June 12, 2025.
2. This transaction was executed in multiple trades at prices ranging from $82.20 to $82.96. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
3. Includes 43,509 restricted stock units that have not yet vested or been delivered to the Reporting Person.
4. This transaction was executed in multiple trades at prices ranging from $83.22 to $84.19. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
5. This transaction was executed in multiple trades at prices ranging from $84.35 to $85.11. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
6. Consists of shares withheld by the Issuer with respect to tax withholding obligations of the Reporting Person upon vesting and delivery of shares of common stock underlying restricted stock units previously granted by the Issuer on March 18, 2021.
7. Includes 42,535 restricted stock units that have not yet vested or been delivered to the Reporting Person.
Diana Scherer, Attorney-in-Fact 09/24/2025
** Signature of Reporting Person Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What insider transactions did GKOS report for Tomas Navratil?

The Form 4 reports multiple dispositions of Glaukos common stock by Tomas Navratil on September 22-23, 2025, executed under a 10b5-1 trading plan adopted June 12, 2025.

At what prices were the GKOS shares sold by the reporting person?

The filing discloses weighted-average execution prices for the trade blocks, with trade prices ranging from $82.20 to $85.11 across the reported transactions.

How many GKOS shares does the reporting person beneficially own after the transactions?

Following the reported transactions, the reporting person beneficially owned 75,907 shares according to the Form 4.

Does the Form 4 mention restricted stock units (RSUs)?

Yes. The filing states the reported beneficial ownership includes unvested RSUs and specifies 42,535 (or 43,509 in a different line) RSUs in the explanations; it also notes shares were withheld to satisfy tax withholding upon RSU vesting.

Were these sales routine or part of a special transaction?

The Form 4 states the sales were effected pursuant to a pre-established Rule 10b5-1 trading plan, indicating planned, routine dispositions under that plan.
Glaukos Corp

NYSE:GKOS

GKOS Rankings

GKOS Latest News

GKOS Latest SEC Filings

GKOS Stock Data

4.67B
55.43M
3.31%
107.34%
5.9%
Medical Devices
Surgical & Medical Instruments & Apparatus
Link
United States
ALISO VIEJO